ARCHIVES

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

This article is from The Cancer Letter archive.

Vol. 29 No. 46 | December 12, 2003

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI Last Month Are Listed

August 29, 2003

DePinho’s Letter to the AAUP

May 30, 2014

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

November 22, 2006

NIH Cancer Nurse Turnover Down to 10%

July 24, 1987

Free Standing Cancer Center Firms Expanding Markets

February 21, 1986